-
Dr. Henchcliffe reports she is on the speakers bureau and advisory board for Allergan and Teva; speakers bureau for Boehringer-Ingelheim, GlaxoSmith-Kline, and Novartis; advisory board for Merz; and is a consultant for Gerson Lehman Group and Guidepoint Global.
-
Treatment and Outcome after Acute Cervical Artery Occlusion with Stroke; Continuous Transcranial Doppler Insonation Can Determine Recanalization Following Acute Ischemic Stroke; Antithrombotic Therapy Appears to be Safe for Patients with Cerebral Cavernous Malformations
-
Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions.
-
Cholinergic system dysfunction, as measured by short latency afferent inhibition, might contribute to gait abnormality in early stages of Parkinsons disease.
-
Use of dexamethasone in community-acquired bacterial meningitis is associated with long-term survival in treated patients.
-
Video-oculography reveals spontaneous or gaze-evoked nystagmus in more than a quarter of patients with isolated superior cerebellar infarction.
-
A novel target for suppression of cortical spreading depression shows promise in rodent models and in patients with medically refractory migraine with aura.
-
Repetitive nerve stimulation studies appear to be safe in patients with modern implantable pacemakers and defibrillators.
-
-
In former, aging, National Football League players, fluid-attenuated inversion recovery scans showed increased total and deep white matter hyperintensity volumes, while diffusion tensor imaging showed decreased fractional anisotropy reflecting white matter disruption, and this is associated with cognitive impairments and depression.
